Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Temozolomide 18 Radiation 7 Magnetic Resonance Spectroscopy 7 Radiotherapy 6 Specimen Handling 4 Lomustine 4 Bevacizumab 4 Aminolevulinic Acid 3 veliparib 2 trametinib 2 lutetium Lu 177 dotatate 2 dabrafenib 2 azeliragon 2 Surgical Procedures, Operative 2 Receptors, Interleukin-8B 2 Nivolumab 2 D2C7-(scdsFv)-PE38KDEL 2 Carboplatin 2 Biopsy 2 varlilumab 1 ulixertinib 1 tinostamustine 1 selinexor 1 ruxolitinib 1 ribociclib 1 relatlimab 1 regorafenib 1 peposertib 1 pembrolizumab 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × ADI PEG20 × 30 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡